Supplementary Material for: Tofacitinib for the management of coexisting pemphigoid nodularis and psoriasis: a case report and review of the literature

Pemphigoid Nodularis (PN) is identified as a rare clinical variant of bullous pemphigoid (BP), often requiring detailed diagnostic methods due to its atypical presentations, with the concurrent occurrence of psoriasis being rare. We report the use of tofacitinib in treating PN combined with psoriasis with significant results. Our research suggests that tofacitinib could effectively treat PN in the presence of psoriasis, offering convenient administration and promising efficacy compared to traditional therapies.